Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2019

Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2

Résumé

Physiological and pathological angiogenesis is mainly regulated by the binding of the vascular endothelial growth factor (VEGF) to its receptors (VEGFRs). Antagonists of VEGFR are very attractive for the treatment of diseases related to excessive angiogenesis. Our previously designed C-terminal alkylated cyclic peptides [YKDEGLEE]-NHR (R = alkyl, arylalkyl) disrupt the interaction between VEGF and VEGFRs in biological assays. In this paper, we described the structural studies of the binding of one of these cyclic peptides named Peptide 3 to the VEGFR1 domain 2 (VEGFR1-D2). The molecular docking and NMR mapping identified the binding site on VEGFR1-D2. The anti-angiogenic effect of our peptide was evaluated by an experiment of VEGF-induced tube formation in two cell lines, retinal cell type RF6/A and vascular endothelial cell type HUVEC. Some new peptides were also synthesized and compared by an ELISA-based assay, in order to verify their ability to disrupt the formation of the complex VEGF-A/VEGFR1. In conclusion, the structural studies of Peptide 3 with VEGFR1-D2 will help the design of more efficient VEGFR antagonists. Moreover, Peptide 3, with improved receptor binding affinity, could be more suitable for VEGFR targeting bioimaging studies once labeled.
Fichier principal
Vignette du fichier
S022352341930193X.pdf (2.79 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02122310 , version 1 (22-10-2021)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Lei Wang, Pascale Coric, Sylvain Broussy, Rossella Di Stasi, Lingyu Zhou, et al.. Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain 2. European Journal of Medicinal Chemistry, 2019, 169, pp.65-75. ⟨10.1016/j.ejmech.2019.02.069⟩. ⟨hal-02122310⟩
89 Consultations
77 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More